India’s ORS market has taken a hit after the government tightened labelling norms, limiting when sugary drinks can be marketed as ORS. The change has disrupted supply and seasonal purchasing patterns, pressuring pharmaceutical firms that rely on predictable demand spikes. Companies now face a tougher path to maintain sales as compliance reduces the category’s appeal.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
